Sigdestad C P, Grdina D J, Connor A M, Hanson W R
Radiat Res. 1986 May;106(2):224-33.
Two thiophosphoroate radiation protectors (WR-2721 and WR-151327) were assessed for their ability to modify the effects of neutron or gamma irradiation on the gastrointestinal tract. Three neutron sources (DOSAR, JANUS, and FERMILAB) were compared to the response obtained after 60Co irradiation. The end points studied were intestinal stem cell survival and LD50(6). DOSAR and JANUS, both fission-spectrum neutrons, showed somewhat different gut sensitivities [LD50(6)] of about 240 and 400 cGy respectively. The intestinal LD50 obtained with FERMILAB neutrons (25 meV) was closer (875 cGy) to that obtained after 60Co (1068 cGy) irradiation. WR-151327 protected against the lethal effects of fission neutron (DOSAR and JANUS) to a greater degree (DMF = 2.2) than with lower LET sources such as FERMILAB neutrons (DMF = 1.7) or 60Co (DMF = 1.7). The results did not correlate with the intestinal stem cell assays where WR-2721 when compared to WR-151327 showed either similar (DOSAR; fission spectrum neutrons) or somewhat better (60Co and FERMILAB neutrons) protection. Possible explanations for the differing results are discussed.
评估了两种硫代磷酸酯辐射防护剂(WR - 2721和WR - 151327)改变中子或γ射线对胃肠道影响的能力。将三个中子源(DOSAR、JANUS和费米实验室)与60Co照射后获得的反应进行了比较。所研究的终点是肠道干细胞存活率和LD50(6)。DOSAR和JANUS这两种裂变谱中子,显示出略有不同的肠道敏感性[LD50(6)],分别约为240和400 cGy。用费米实验室中子(25 meV)获得的肠道LD50(875 cGy)更接近60Co照射后获得的数值(1068 cGy)。WR - 151327对裂变中子(DOSAR和JANUS)的致死效应的防护程度(剂量修正因子 = 2.2)高于低传能线密度源,如费米实验室中子(剂量修正因子 = 1.7)或60Co(剂量修正因子 = 1.7)。结果与肠道干细胞检测不相关,在该检测中,与WR - 151327相比,WR - 2721显示出相似的防护效果(DOSAR;裂变谱中子)或略好的防护效果(60Co和费米实验室中子)。讨论了结果差异的可能解释。